Members include University of Copenhagen’s Arne Astrup, M.D., Ph.D., Pennington Biomedical Research Center’s Claude Bouchard, Ph.D., and Scripps Nutrition and Metabolic Research Center’s Ken Fujioka, M.D.
Pathway Genomics has established a world-leading scientific advisory board. Among the board members are Arne Astrup, M.D., Ph.D., head of the department of human nutrition at the University of Copenhagen, Claude Bouchard, Ph.D., executive director of the Pennington Biomedical Research Center, and Ken Fujioka, M.D., director of the Scripps Nutrition and Metabolic Research Center – all known for their breakthrough discoveries in obesity research, nutrition and weight management clinical trials.
“Collaborating with outside experts of this caliber is vital for Pathway to bring the latest scientific and technological advancements and methods in genomic and translational medicine to health care providers and their patients,” said Michael Nova, M.D., Pathway Genomics’ chief medical officer. “Pathway’s mission is to educate and empower people by providing actionable genetic information – our scientific advisory board is an essential part of that effort.”
Pathway’s scientific advisory board consists of 10 leaders in various fields including behavioral genetics, bioinformatics, biostatistics, endocrinology, human epigenetics, metabolism, nutrigenomics, nutrition, obesity and exercise genetics, oncology, and weight management. To view the company’s full scientific advisory board, visit www.pathway.com/sab.
Comments are closed.